Overcoming underutilization of continuous glucose monitoring devices with diabetes among disparate populations

Document Type

Journal Article

Publication Date

10-24-2025

Journal

Endocrine research

DOI

10.1080/07435800.2025.2577643

Keywords

Cardiovascular-kidney-metabolic; continuous glucose monitoring devices; diabetes; underserved

Abstract

INTRODUCTION: Continuous glucose monitoring (CGM) demonstrates significant benefits in glycemic control for both type 1 and type 2 diabetes, including reductions in HbA1c, increased time-in-range, and decreased hypoglycemia. METHODS: In this article, we review the recent American Diabetes Association guidelines recommending real-time CGM for adults with type 2 diabetes, including those not using insulin. RESULTS: While acknowledging the documented advantages, CGM remains underutilized, with many barriers, particularly in primary care settings and among racially diverse or lower socioeconomic populations. DISCUSSION: This review outlines positive strategies to address barriers to CGM-adoption, optimize glycemic control and thereby potentially reduce cardiovascular-kidney-metabolic complications.

Department

Clinical Research and Leadership

Share

COinS